THURSDAY, Feb. 19, 2015 (HealthDay News) -- When expectant mothers are exposed to plastics chemicals called phthalates during the first trimester, their male offspring may have a greater risk of infertility later in life, a new study suggests.
Boys exposed to the chemical diethylhexyl phthalate (DEHP) may be born with a significantly shorter anogenital distance than those not exposed to these chemicals. Anogenital distance is the distance between the anus and the genitals. A shorter anogenital distance has been linked to infertility and low sperm count, the researchers explained.
"We saw these changes even though moms' exposure to DEHP has dropped 50 percent in the past 10 years," said lead researcher Shanna Swan, a professor of preventive medicine and obstetrics, gynecology and reproductive medicine at the Icahn School of Medicine at Mount Sinai in New York City.
"Therefore, we have not found a safe level of phthalate exposure for pregnant women," she contended.
Swan said that this study cannot prove that these boys will have fertility problems as adults or that DEHP causes these problems. However, animal studies have implicated the chemical in male reproductive problems. Based on the data from this study, Swan believes there is a strong association between exposure to DEHP and fertility in human males.
DEHP is used to soften plastics. Most exposure results from eating foods that pick up the chemical during processing, Swan said.
"Since food is the largest source of DEHP for consumers, it is difficult for pregnant women to minimize exposure," she said. "Eating unprocessed food will likely help. However, eliminating DEHP from food really has to be done by food producers."
The chemical is also found in medical tubing and in a variety of products, including flooring, wallpaper, lacquers and personal care products, Swan said.
The report was published Feb. 19 in the journal Human Reproduction.
For the study, Swan's team collected data on almost 800 pregnant women and their infants.
Specifically, the researchers found that exposure in the womb to three types of DEHP was associated with a significantly shorter anogenital distance in boys, but not in girls.
A group representing the chemical industry took issue with the study, however.
In a statement, the American Chemistry Council (ACC) stressed that the study only examined one type of phthalate, not all versions of the chemical. And it said that phthalates are "one of the most widely studied family of chemicals in use today."
The ACC added that DEHP "is known to break down into its metabolites within minutes after it enters the body. Information collected by the Centers for Disease Control and Prevention over the last 10 years indicates that, despite the fact that phthalates are used in many products, exposure from all sources combined is extremely low -- much lower than the levels established as safe by scientists at regulatory agencies."
But another expert says phthalate exposure may not be benign. Dr. Kenneth Spaeth, director of the Occupational and Environmental Medicine Center at North Shore University Hospital in Manhasset, N.Y., said, "virtually everyone in the U.S. experiences continual exposure to phthalates."
And, a number of studies have tied the chemicals with changes in developing fetuses. "Phthalates, in particular, have been shown in both human and animal studies to interfere with normal fetal development," he said.
This study supports what has been demonstrated before, that phthalate exposure in the first trimester is linked to male reproductive development, Spaeth said. "This study is an important step forward in establishing this effect because the study included a much larger number of individuals than prior studies and helps identify one particular agent, DEHP, as an important contributor to this effect," he said.
Additionally, this study shows the importance of exposure in the first trimester as a critical window for the effect of phthalates on the male reproductive system. "On the whole, given these features, the authors have contributed important information about the public health risk posed by phthalates," Spaeth suggested.
For more on phthalates, visit the U.S. National Institutes of Health.
SOURCES: Shanna Swan, Ph.D., professor, preventivemedicine and obstetrics, gynecology and reproductive medicine, Icahn School of Medicine at Mount Sinai, New York City; Kenneth Spaeth, M.D., M.P.H., director, Occupational and Environmental Medicine Center, North Shore University Hospital, Manhasset, N.Y.; Feb. 19, 2015, statement, American Chemistry Council; Feb. 19, 2015, Human Reproduction
Copyright © 2015 HealthDay. All rights reserved.